Onconic Therapeutics476060

Largest holderJeil Pharmaceutical44.56%$175M

Filed holders115% or more, plus insiders

Price and institutional trades

1Y 2Y

$8.77−12.7%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

$175M · 2026-03-0444.56%

$16M · 2026-03-043.95%

$2.0M · 2025-02-062.10%

$1.8M · 2024-12-231.87%

$5.7M · 2026-03-041.45%

$1.1M · 2024-12-231.11%

$3.9M · 2026-03-041.00%

$2.8M · 2026-07-030.71%−0.20pp

3 other related parties$5.1M1.30%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Indirect-only holders

$86M · indirect21.94%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-07-03	-	1.15 → 0.71%	−$2.1M	-	Filing
2026-06-12	-	1.21 → 1.15%	−$371K	-	Filing
2026-04-17	-	0.91 → 1.21%	+$2.5M	-	Filing
2026-03-04	2026-02-25	52.93 → 51.28%	−$15M	$13.81	Filing
2026-01-12	2026-01-06	55.61 → 52.93%

Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%21.94%

$54M · indirect13.81%

Jeil Pharmaceutical 3.00% → Onconic Therapeutics 44.56%1.34%
Jeil Pharma Holdings 56.86% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%12.48%

$11M · indirect2.82%

Jeil Pharmaceutical 6.32% → Onconic Therapeutics 44.56%2.82%

$4.8M · indirect1.21%

Jeil Pharmaceutical 2.40% → Onconic Therapeutics 44.56%1.07%
Jeil Pharma Holdings 0.65% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%0.14%

$2.5M · indirect0.63%

Jeil Pharma Holdings 2.85% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%0.63%

$1.6M · indirect0.41%

Jeil Pharma Holdings 1.88% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%0.41%

$736K · indirect0.19%

Jeil Pharmaceutical 0.37% → Onconic Therapeutics 44.56%0.16%
Jeil Pharma Holdings 0.10% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%0.02%

$717K · indirect0.18%

Jeil Pharmaceutical 0.32% → Onconic Therapeutics 44.56%0.14%
Jeil Pharma Holdings 0.18% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%0.04%

No direct stake in the filings. It may be under 5% or filed before November 2024, so actual holdings may be larger.

Show 1 unchanged reports

Filed	Changed	Holder	Change	Before → after	Amount	Avg buy price
2025-12-24	-			48.61 → 48.61%	+$221M	-	Filing

11 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched

· avg $1.94 (partial)

· avg $6.60 (partial)

Kim JohnInsider report

Jeil PharmaceuticalInsider report